Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17059562rdf:typepubmed:Citationlld:pubmed
pubmed-article:17059562lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C0023689lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C0041538lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C1539907lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:17059562lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:17059562pubmed:issue6lld:pubmed
pubmed-article:17059562pubmed:dateCreated2007-1-16lld:pubmed
pubmed-article:17059562pubmed:abstractTextIt has been proposed that in autosomal recessive juvenile parkinsonism (AR-JP), a ubiquitin ligase (E3) Parkin, which is involved in endoplasmic reticulum-associated degradation (ERAD), lacks E3 activity. The resulting accumulation of Parkin-associated endothelin receptor-like receptor (Pael-R), a substrate of Parkin, leads to endoplasmic reticulum stress, causing neuronal death. We previously reported that human E3 HRD1 in the endoplasmic reticulum protects against endoplasmic reticulum stress-induced apoptosis. This study shows that HRD1 was expressed in substantia nigra pars compacta (SNC) dopaminergic neurons and interacted with Pael-R through the HRD1 proline-rich region, promoting the ubiquitylation and degradation of Pael-R. Furthermore, the disruption of endogenous HRD1 by small interfering RNA (siRNA) induced Pael-R accumulation and caspase-3 activation. We also found that ATF6 overexpression, which induced HRD1, accelerated and caused Pael-R degradation; the suppression of HRD1 expression by siRNA partially prevents this degradation. These results suggest that in addition to Parkin, HRD1 is also involved in the degradation of Pael-R.lld:pubmed
pubmed-article:17059562pubmed:languageenglld:pubmed
pubmed-article:17059562pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:citationSubsetIMlld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17059562pubmed:statusMEDLINElld:pubmed
pubmed-article:17059562pubmed:monthDeclld:pubmed
pubmed-article:17059562pubmed:issn0022-3042lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:NagashimaKazu...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:OkumaYasunobu...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:NomuraYasuyuk...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:OrbaYasukoYlld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:UeharaTakashi...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:MatsumuraSato...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:TakahashiRyos...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:FujitaniNobor...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:KanekoMasayuk...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:OmuraTomohiro...lld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:KubotaKyokoKlld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:HataAkihisaAlld:pubmed
pubmed-article:17059562pubmed:authorpubmed-author:MurahashiKari...lld:pubmed
pubmed-article:17059562pubmed:issnTypePrintlld:pubmed
pubmed-article:17059562pubmed:volume99lld:pubmed
pubmed-article:17059562pubmed:ownerNLMlld:pubmed
pubmed-article:17059562pubmed:authorsCompleteYlld:pubmed
pubmed-article:17059562pubmed:pagination1456-69lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:meshHeadingpubmed-meshheading:17059562...lld:pubmed
pubmed-article:17059562pubmed:year2006lld:pubmed
pubmed-article:17059562pubmed:articleTitleA ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.lld:pubmed
pubmed-article:17059562pubmed:affiliationDepartment of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.lld:pubmed
pubmed-article:17059562pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17059562pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7316entrezgene:pubmedpubmed-article:17059562lld:entrezgene
entrez-gene:2861entrezgene:pubmedpubmed-article:17059562lld:entrezgene
entrez-gene:84447entrezgene:pubmedpubmed-article:17059562lld:entrezgene
entrez-gene:74126entrezgene:pubmedpubmed-article:17059562lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17059562lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17059562lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17059562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17059562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17059562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17059562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17059562lld:pubmed